1. Home
  2. TYRA vs SAH Comparison

TYRA vs SAH Comparison

Compare TYRA & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$28.28

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Sonic Automotive Inc.

SAH

Sonic Automotive Inc.

HOLD

Current Price

$79.46

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
SAH
Founded
2018
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.4B
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
TYRA
SAH
Price
$28.28
$79.46
Analyst Decision
Strong Buy
Buy
Analyst Count
11
8
Target Price
$47.50
$78.25
AVG Volume (30 Days)
807.7K
202.7K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
2.07%
EPS Growth
N/A
N/A
EPS
N/A
1.79
Revenue
N/A
$9,951,630,000.00
Revenue This Year
N/A
$4.61
Revenue Next Year
N/A
$4.16
P/E Ratio
N/A
$44.53
Revenue Growth
N/A
0.86
52 Week Low
$8.98
$54.11
52 Week High
$40.65
$89.38

Technical Indicators

Market Signals
Indicator
TYRA
SAH
Relative Strength Index (RSI) 42.75 50.30
Support Level $27.40 $78.96
Resistance Level $31.57 $84.75
Average True Range (ATR) 1.98 2.67
MACD 0.26 -0.74
Stochastic Oscillator 42.12 38.98

Price Performance

Historical Comparison
TYRA
SAH

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About SAH Sonic Automotive Inc.

Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 111 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores in 10 states, 16 collision centers, and 14 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 56% of new-vehicle revenue. BMW is the largest brand at about 23%. 2025's revenue was $15.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.

Share on Social Networks: